Pain is a major matter for patients with multiple sclerosis; treatment response is frequently
inadequate, with a significant impact on quality of life. The estimated prevalence of pain in …

Background Both chronic and acute pain have been cited as the most common symptoms
amongst patients with multiple sclerosis (MS), with recent prevalence estimates as high as …

Pain is a common symptom in multiple sclerosis (MS) and was recently estimated to be
experienced by up to 75% of patients. Nociceptive and neuropathic pain in MS may be …

About half of patients with multiple sclerosis (MS) report pain; treatment for pain alone
accounts for nearly 30% of the total use of medications for the management of all MS-related …

Introduction The prevalence of pain in Multiple Sclerosis (MS) is estimated to be between 29-
86% depending on various stages of the disease. According to a recent mechanism-based …

Pharmacological treatment of pain in multiple sclerosis (MS) is challenging due to the many
underlying pathophysiological mechanisms. Few controlled trials show adequate pain …

Pain is common in patients with multiple sclerosis (MS), but estimates of its prevalence have
varied widely. The literature describing pain in MS patients spans four decades and has …

Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system
and can cause various types of pain including ongoing extremity pain, Lhermitte's …

Introduction/Background Chronic pain is common and significantly impacts on the lives of
persons with multiple sclerosis (MS). Various types of non-pharmacological interventions …

Chronic pain is defined as any consistent pain lasting more than 12 weeks; chronic pain
afflicts 25% of the world's population. The most common form of chronic pain is chronic …